Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Newleaf Symbiotics Inc. has 6 pending office actions in Biotechnology & Pharmaceuticals. Each matter is assigned to a distinct examiner and a distinct art unit, so the recorded workload is distributed across separate examination relationships and technical classifications.
FAN, WEIHUA is the busiest examiner, with 1 pending matter. The data does not identify a dominant examiner or art-unit concentration. Counsel may therefore prioritize matter-specific prosecution analysis while maintaining consistent disclosure and claim terminology across the portfolio.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| §112 only | 2 (33%) |
| Multi-statute (no §101) | 1 (17%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FAN, WEIHUA | 1 | 83.3% | +12.7% |
| ARIANI, KADE | 1 | 75.0% | +32.0% |
| TICHY, JENNIFER M.H. | 1 | 64.6% | +34.4% |
| DICKENS, AMELIA NICOLE | 1 | 47.2% | +21.6% |
| SCOTLAND, REBECCA LYNN | 1 | 0.0% | +0.0% |
| PURDY, KYLE A | 1 | 41.0% | +35.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18004937 | MICROBIAL INOCULANT FORMULATIONS | SCOTLAND, REBECCA LYNN | 28d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17056797 | MICROBIAL MICROCAPSULE COMPOSITIONS, METHODS AND RELATED METHODS | PURDY, KYLE A | 18d overdue |
| 18583042 | METHYLOBACTERIUM COMPOSITIONS FOR FUNGAL DISEASE CONTROL | TICHY, JENNIFER M.H. | 9d overdue |
| 19299056 | METHODS AND COMPOSITIONS FOR CONTROLLING ROOT LESION NEMATODES | FAN, WEIHUA | — |
| 19022071 | MICROBIAL FERMENTATION METHODS AND COMPOSITIONS | ARIANI, KADE | — |
| 18488471 | METHYLOBACTERIUM STRAINS FOR CONTROLLING CORN ROOTWORM | DICKENS, AMELIA NICOLE | — |
| Art Unit | Apps |
|---|---|
| 1663 | 1 |
| 1651 | 1 |
| 1653 | 1 |
| 1645 | 1 |
| 1615 | 1 |
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19299056 | METHODS AND COMPOSITIONS FOR CONTROLLING ROOT LESION NEMATODES | FAN, WEIHUA | 1663 | Other | Non-Final OA | — | Pending | Aug 13, 2025 |
| 19022071 | MICROBIAL FERMENTATION METHODS AND COMPOSITIONS | ARIANI, KADE | 1651 | §112Other | Non-Final OA | — | Pending | Jan 15, 2025 |
| 18583042 | METHYLOBACTERIUM COMPOSITIONS FOR FUNGAL DISEASE CONTROL | TICHY, JENNIFER M.H. | 1653 | §103 | Non-Final OA | 9d overdue | Pending | Feb 21, 2024 |
| 18488471 | METHYLOBACTERIUM STRAINS FOR CONTROLLING CORN ROOTWORM | DICKENS, AMELIA NICOLE | 1645 | §112 | Final Rejection | — | Pending | Oct 17, 2023 |
| 18004937 | MICROBIAL INOCULANT FORMULATIONS | SCOTLAND, REBECCA LYNN | 1615 | §103§112 | Final Rejection | 28d | Pending | Jan 10, 2023 |
| 17056797 | MICROBIAL MICROCAPSULE COMPOSITIONS, METHODS AND RELATED METHODS | PURDY, KYLE A | 1611 | §103 | Non-Final OA | 18d overdue | Pending | Nov 19, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNewleaf Symbiotics Inc. has 6 pending office actions as of October 2026, spread across 6 art units and 6 examiners.
Weihua Fan has the most, with 1 of Newleaf Symbiotics Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
